104 related articles for article (PubMed ID: 21848861)
1. Experimental research with synthetic copolymer-coated cardiopulmonary bypass circuits: inflammatory and thrombogenicity analysis.
Gabriel EA; Montevilla FM; Chida VV; Dias FN; Montoya CV; Otsubo H; Pires ZF; Nogaroto SL
Artif Organs; 2012 Jan; 36(1):110-4. PubMed ID: 21848861
[TBL] [Abstract][Full Text] [Related]
2. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
[TBL] [Abstract][Full Text] [Related]
3. The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study.
Senay S; Toraman F; Gunaydin S; Kilercik M; Karabulut H; Alhan C
Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):93-9. PubMed ID: 18801802
[TBL] [Abstract][Full Text] [Related]
4. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass.
Rubens FD; Nathan H; Labow R; Williams KS; Wozny D; Karsh J; Ruel M; Mesana T
Ann Thorac Surg; 2005 Feb; 79(2):655-65. PubMed ID: 15680854
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
[TBL] [Abstract][Full Text] [Related]
6. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
Noguchi M; Eishi K; Tada S; Yamachika S; Hazama S; Izumi K; Tanigawa K
Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
[TBL] [Abstract][Full Text] [Related]
7. Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor transfusions in coronary artery surgery.
Südkamp M; Mehlhorn U; Reza Raji M; Hekmat K; Easo J; Geissler HJ; Sindhu D; de Vivie R
Thorac Cardiovasc Surg; 2002 Feb; 50(1):5-10. PubMed ID: 11847596
[TBL] [Abstract][Full Text] [Related]
8. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
[TBL] [Abstract][Full Text] [Related]
9. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
[TBL] [Abstract][Full Text] [Related]
10. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of PHISIO-coated sets for pediatric cardiac surgery.
Hoel TN; Thiara AS; Videm V; Fiane AE; Mollnes TE; Castellheim A; Svennevig JL
Scand Cardiovasc J; 2009 Apr; 43(2):129-35. PubMed ID: 19294579
[TBL] [Abstract][Full Text] [Related]
12. [Experimental study on heparin-free cardiopulmonary bypass using nafamostat mesilate (FUT-175) and heparin-coated circuit].
Takano H; Miyamoto Y; Kaneko M; Matsuwaka R; Kuratani T; Amemiya A; Nakano S; Matsuda H
Nihon Kyobu Geka Gakkai Zasshi; 1993 Nov; 41(11):2166-73. PubMed ID: 8283086
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of biocompatible cardiopulmonary bypass circuit use during pediatric open heart surgery.
Deptula J; Glogowski K; Merrigan K; Hanson K; Felix D; Hammel J; Duncan K
J Extra Corpor Technol; 2006 Mar; 38(1):22-6. PubMed ID: 16637519
[TBL] [Abstract][Full Text] [Related]
14. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress.
Sohn N; Marcoux J; Mycyk T; Krahn J; Meng Q
Perfusion; 2009 Jul; 24(4):231-7. PubMed ID: 19858237
[TBL] [Abstract][Full Text] [Related]
15. A comparative evaluation of the effect of pump type and heparin-coated surfaces on platelets during cardiopulmonary bypass.
Misoph M; Babin-Ebell J; Schwender S
Thorac Cardiovasc Surg; 1997 Dec; 45(6):302-6. PubMed ID: 9477463
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of a silicone coated hollow fiber oxygenator.
Shimono T; Shomura Y; Tani K; Shimamoto A; Hioki I; Tokui T; Onoda K; Takao M; Shimpo H; Yada I
ASAIO J; 1997; 43(5):M735-9. PubMed ID: 9360143
[TBL] [Abstract][Full Text] [Related]
18. Effect of a miniaturized cardiopulmonary bypass system on the inflammatory response and cardiac function in neonatal piglets.
Yoshizumi K; Ishino K; Ugaki S; Ebishima H; Kotani Y; Kasahara S; Sano S
Artif Organs; 2009 Nov; 33(11):941-6. PubMed ID: 19817733
[TBL] [Abstract][Full Text] [Related]
19. Nafamostat mesilate reduces blood-foreign surface reactions similar to biocompatible materials.
Usui A; Hiroura M; Kawamura M; Hibi M; Yoshida K; Murakami F; Tomita Y; Ooshima H; Murase M
Ann Thorac Surg; 1996 Nov; 62(5):1404-11. PubMed ID: 8893576
[TBL] [Abstract][Full Text] [Related]
20. Effect of polymer coating (poly 2-methoxyethylacrylate) of the oxygenator on hemostatic markers during cardiopulmonary bypass in children.
Eisses MJ; Geiduschek JM; Jonmarker C; Cohen GA; Chandler WL
J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):28-34. PubMed ID: 17289476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
